Related references
Note: Only part of the references are listed.MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification
Mark W. Zimmerman et al.
CANCER DISCOVERY (2018)
Drugging the 'undruggable' cancer targets
Chi V. Dang et al.
NATURE REVIEWS CANCER (2017)
Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials
Mario Fiore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
Michelle L. O'Donoghue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial
Hamed Emami et al.
ATHEROSCLEROSIS (2015)
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
L. L. Wang et al.
BRITISH JOURNAL OF CANCER (2015)
Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma
Poonam Sonawane et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Pou5f1/Oct4 Promotes Cell Survival via Direct Activation of mych Expression during Zebrafish Gastrulation
Kay Kotkamp et al.
PLOS ONE (2014)
Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
Xiao-Na Pan et al.
PLOS ONE (2014)
DSSylation, a novel protein modification targets proteins induced by oxidative stress, and facilitates their degradation in cells
Yinghao Zhang et al.
PROTEIN & CELL (2014)
Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Neuroinflammation, Heat Shock Protein 27 Phosphorylation, and Cell Cycle: Role and Targeting
Fadi Maged Shokry Gurgis et al.
MOLECULAR PHARMACOLOGY (2014)
Neuroblastoma of Undifferentiated Subtype, Prognostic Significance of Prominent Nucleolar Formation, and MYC/MYCN Protein Expression
Larry L. Wang et al.
CANCER (2013)
SnapShot: p38 MAPK Signaling
Natalia Trempolec et al.
CELL (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Reciprocal Regulation of Akt and Oct4 Promotes the Self-Renewal and Survival of Embryonal Carcinoma Cells
Yuanji Lin et al.
MOLECULAR CELL (2012)
Phosphorylation regulates human OCT4
Justin Brumbaugh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms
Pixu Liu et al.
NATURE MEDICINE (2011)
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis
Nina Ilic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 Activity
Binod Kumar et al.
CANCER RESEARCH (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oct4-Induced Pluripotency in Adult Neural Stem Cells
Jeong Beom Kim et al.
CELL (2009)
Post-Translational Regulation of Oct4 Transcriptional Activity
Jonathan P. Saxe et al.
PLOS ONE (2009)
Specific Knockdown of OCT4 in Human Embryonic Stem Cells by Inducible Short Hairpin RNA Interference
Gaetano Zafarana et al.
STEM CELLS (2009)
Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming
Rudolf Jaenisch et al.
CELL (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Nuclear reprogramming and pluripotency
Konrad Hochedlinger et al.
NATURE (2006)
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Joel D. Nelson et al.
NATURE PROTOCOLS (2006)
Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells
DC Hay et al.
STEM CELLS (2004)
Retinoid therapy of high-risk neuroblastoma
CP Reynolds et al.
CANCER LETTERS (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export
WY Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Retinoid therapy of childhood cancer
CP Reynolds et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2001)